ClearPoint Neuro’s 80,000 rpm MR Drill Clears FDA, Cuts Procedure Time
ClearPoint Neuro’s Velocity Alpha MR Surgical Drill received FDA 510(k) clearance and completed its first four-trajectory clinical use, promising up to one-hour procedure time savings. Operating at 80,000 rpm for MR and OR environments, the drill extends the company’s device portfolio and will link to its upcoming robotic navigation platform.
1. FDA Clearance and First Clinical Use
On April 22, 2026, the FDA granted 510(k) clearance for the Velocity Alpha MR High Speed Surgical Drill, and ClearPoint Neuro completed the first clinical procedure using the system in a four-trajectory trial. This milestone marks the drill’s operational debut within the SmartFrame navigation platform.
2. Drill Design and Technical Specifications
The pneumatic drill reaches up to 80,000 rpm with a low noise profile and features a universal one-click cutter system and telescoping functionality. Specialized drill bits provide tactile feedback during bone access, streamlining both MR and operating room workflows.
3. Integration with Product Ecosystem
Manufactured by adeor medical AG, the Velocity Alpha drill expands ClearPoint Neuro’s product portfolio to support complex cell- and gene-therapy procedures. Its integration with the SmartFrame platform aims to reduce case times and enhance procedural efficiency across neurosurgical applications.
4. Future Outlook and Growth Strategy
ClearPoint Neuro plans to adapt the drill for its upcoming robotic navigation platform, positioning the product for broader adoption. This strategic addition reinforces the company’s connected ecosystem and supports its long-term growth objectives in device-enabled neurosurgical therapies.